Skip to main content

Study Shows WATS3D Biopsy Increases Detection of Pre-Cancer in the Esophagus by 50% in Post-Ablation Patients

CDx Diagnostics announced today that a new study adds to the growing body of evidence supporting the use of Wide Area Transepithelial Sampling with 3-Dimensional analysis (WATS3D) as a surveillance tool in patients who have received ablation therapy for Barrett’s esophagus.
http://www.digitaljournal.com/pr/1523611

No Comments yet!

Your Email address will not be published.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2022 Esophageal Cancer Education Foundation- by domino